NASDAQ:AEMD Aethlon Medical Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Aethlon Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. $0.99 -0.02 (-1.98%) (As of 07/6/2022 12:00 AM ET) Add Compare Share Today's Range$0.99▼$1.0850-Day Range$0.89▼$1.6152-Week Range$0.88▼$6.22Volume518,680 shsAverage Volume304,621 shsMarket Capitalization$15.67 millionP/E RatioN/ADividend YieldN/APrice Target$6.50 ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media Aethlon Medical MarketRank™ ForecastAnalyst RatingBuy3.00 Rating ScoreUpside/Downside556.6% Upside$6.50 Price TargetShort InterestHealthy1.41% of Shares Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.58Based on 11 Articles This WeekInsider TradingN/AProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as 30% analysis score, 20% valuation score, 10% short interest score, 10% dividend score, 10% sustainability score, 10% news and social score, and 10% insider trading score.1.57 out of 5 starsMedical Sector949th out of 1,426 stocksSurgical & Medical Instruments Industry97th out of 136 stocks 3.5 Analyst's Opinion Consensus RatingAethlon Medical has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $6.50, Aethlon Medical has a forecasted upside of 556.6% from its current price of $0.99.Amount of Analyst CoverageAethlon Medical has received no research coverage in the past 90 days. Previous Next 5.0 Short Interest Percentage of Shares Shorted1.41% of the outstanding shares of Aethlon Medical have been sold short.Short Interest Ratio / Days to CoverAethlon Medical has a short interest ratio ("days to cover") of 0.7, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Aethlon Medical has recently decreased by 28.45%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldAethlon Medical does not currently pay a dividend.Dividend GrowthAethlon Medical does not have a long track record of dividend growth. Previous Next 0.0 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for AEMD. Previous Next 2.0 News and Social Media Coverage News SentimentAethlon Medical has a news sentiment score of 0.58. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.85 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 11 news articles for Aethlon Medical this week, compared to 0 articles on an average week.Search InterestOnly 5 people have searched for AEMD on MarketBeat in the last 30 days. This is a decrease of -38% compared to the previous 30 days.MarketBeat FollowsOnly 4 people have added Aethlon Medical to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Aethlon Medical insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 1.17% of the stock of Aethlon Medical is held by insiders.Percentage Held by InstitutionsOnly 10.58% of the stock of Aethlon Medical is held by institutions. Previous Next 0.6 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Aethlon Medical is -1.41, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Aethlon Medical is -1.41, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioAethlon Medical has a P/B Ratio of 0.90. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive AEMD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Aethlon Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address About Aethlon Medical (NASDAQ:AEMD) StockAethlon Medical, Inc., a medical technology company, focuses on developing products to diagnose and treat life and organ threatening diseases in the United States. The company develops Aethlon Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses from the human circulatory system. It is also developing TauSome, an exosomal biomarker candidate to diagnose chronic traumatic encephalopathy in living individuals. Aethlon Medical, Inc. has a collaboration with the University of Pittsburgh Medical Center Hillman Cancer Center for studies related to head and neck cancer. The company was founded in 1999 and is based in San Diego, California.Read More AEMD Stock News HeadlinesJuly 5, 2022 | americanbankingnews.comAethlon Medical, Inc. (NASDAQ:AEMD) Short Interest Down 28.4% in JuneJuly 3, 2022 | americanbankingnews.comEquities Analysts Issue Forecasts for Aethlon Medical, Inc.'s FY2023 Earnings (NASDAQ:AEMD)July 2, 2022 | americanbankingnews.comStockNews.com Initiates Coverage on Aethlon Medical (NASDAQ:AEMD)July 1, 2022 | americanbankingnews.comAnalysts Issue Forecasts for Aethlon Medical, Inc.'s Q1 2023 Earnings (NASDAQ:AEMD)June 29, 2022 | seekingalpha.comAethlon Medical, Inc.'s (AEMD) CEO Chuck Fisher on Q4 2022 Results - Earnings Call TranscriptJune 29, 2022 | finance.yahoo.comAEMD: Positive Results in a Range of Conditions, Including COVID-19 & MonkeypoxJune 28, 2022 | seekingalpha.comAethlon Medical Q4 2022 Earnings PreviewJune 27, 2022 | benzinga.comEarnings Outlook For Aethlon MedicalJune 26, 2022 | americanbankingnews.comAethlon Medical (AEMD) to Release Earnings on TuesdayJune 22, 2022 | americanbankingnews.comStockNews.com Begins Coverage on Aethlon Medical (NASDAQ:AEMD)June 21, 2022 | finance.yahoo.comAethlon Medical to Release Fiscal Year End Financial Results and Host Conference Call on June 28, 2022June 15, 2022 | americanbankingnews.comAethlon Medical (NASDAQ:AEMD) Coverage Initiated by Analysts at StockNews.comJune 11, 2022 | americanbankingnews.comAethlon Medical, Inc. (NASDAQ:AEMD) Sees Significant Growth in Short InterestMay 24, 2022 | finance.yahoo.com/C O R R E C T I O N -- Aethlon Medical, Inc./May 21, 2022 | finance.yahoo.comIs Aethlon Medical (NASDAQ:AEMD) In A Good Position To Deliver On Growth Plans?May 9, 2022 | finance.yahoo.comAEMD: Effectiveness of Hemopurifier on COVID-19 Variants In Vitro Indicates Device’s Potential RangeMay 2, 2022 | finance.yahoo.comAethlon Medical Publishes In Vitro Studies Demonstrating Hemopurifier Resin Binding of Seven Clinically Relevant COVID-19 VariantsFebruary 15, 2022 | finance.yahoo.comAEMD: Positive Takeaways from Plan to Expand Clinical EffortsFebruary 13, 2022 | benzinga.comAethlon Medical's Earnings OutlookFebruary 11, 2022 | seekingalpha.comAethlon Medical Q3 2022 Earnings PreviewJanuary 31, 2022 | finance.yahoo.comAethlon Medical to Release Third Quarter Financial Results and Host Conference Call on February 14, 2022November 30, 2021 | finance.yahoo.comHere's Why We're Not Too Worried About Aethlon Medical's (NASDAQ:AEMD) Cash Burn SituationNovember 12, 2021 | finance.yahoo.comAEMD: Strong balance sheet, expanded management team & new CRO relationship expected to facilitate clinical effortsNovember 10, 2021 | benzinga.comAethlon Medical's Return On Capital Employed InsightsNovember 2, 2021 | finance.yahoo.comAethlon Medical to Release Second Quarter Financial Results and Host Conference Call on November 9, 2021See More Headlines Industry, Sector and Symbol Stock ExchangeNASDAQ Industry Surgical & medical instruments Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:AEMD CUSIPN/A CIK773910 Webwww.aethlonmedical.com Phone(858) 459-7800FaxN/AEmployees10Year FoundedN/ACompany Calendar Last Earnings11/09/2021Today7/06/2022Next Earnings (Estimated)8/08/2022Fiscal Year End3/31/2023Price Target and Rating Average Stock Price Forecast$6.50 High Stock Price Forecast$9.00 Low Stock Price Forecast$4.00 Forecasted Upside/Downside+556.6%Consensus RatingBuy Rating Score (0-4)3 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)($0.70) Trailing P/E RatioN/A Forward P/E Ratio1.27 P/E GrowthN/ANet Income$-10,420,000.00 Net Margins-3,542.86% Pretax Margin-3,544.56% Return on Equity-48.91% Return on Assets-45.75% Debt Debt-to-Equity RatioN/A Current Ratio9.95 Quick Ratio9.95 Sales & Book Value Annual Sales$290,000.00 Price / Sales54.04 Cash FlowN/A Price / Cash FlowN/A Book Value$1.10 per share Price / Book0.90Miscellaneous Outstanding Shares15,830,000Free Float15,645,000Market Cap$15.67 million OptionableNot Optionable Beta0.87 Aethlon Medical Frequently Asked Questions Should I buy or sell Aethlon Medical stock right now? 1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Aethlon Medical in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" Aethlon Medical stock. View analyst ratings for Aethlon Medical or view top-rated stocks. What is Aethlon Medical's stock price forecast for 2022? 1 brokers have issued 1 year target prices for Aethlon Medical's shares. Their AEMD stock forecasts range from $4.00 to $9.00. On average, they predict Aethlon Medical's stock price to reach $6.50 in the next year. This suggests a possible upside of 556.6% from the stock's current price. View analysts' price targets for Aethlon Medical or view top-rated stocks among Wall Street analysts. How has Aethlon Medical's stock price performed in 2022? Aethlon Medical's stock was trading at $1.86 at the start of the year. Since then, AEMD stock has decreased by 46.8% and is now trading at $0.99. View the best growth stocks for 2022 here. When is Aethlon Medical's next earnings date? Aethlon Medical is scheduled to release its next quarterly earnings announcement on Monday, August 8th 2022. View our earnings forecast for Aethlon Medical. How were Aethlon Medical's earnings last quarter? Aethlon Medical, Inc. (NASDAQ:AEMD) posted its quarterly earnings results on Tuesday, November, 9th. The medical equipment provider reported ($0.13) earnings per share for the quarter, beating the consensus estimate of ($0.15) by $0.02. The medical equipment provider had revenue of $0.13 million for the quarter, compared to analysts' expectations of $0.21 million. Aethlon Medical had a negative net margin of 3,542.86% and a negative trailing twelve-month return on equity of 48.91%. During the same period last year, the firm posted ($0.15) earnings per share. View Aethlon Medical's earnings history. Who are Aethlon Medical's key executives? Aethlon Medical's management team includes the following people: Dr. Charles J. Fisher Jr., M.D., CEO, Director & Member of Extracorporeal Therapy Advisory Board (Age 75, Pay $509.14k)Mr. James B. Frakes M.B.A., CFO, Sr. VP of Fin. & Sec. (Age 65, Pay $385k)Mr. Steven P. Larosa M.D., Chief Medical Officer & Acting Chief Scientific OfficerMr. Guy F. Cipriani BS (Eng.), MBA, Sr. VP, Chief Bus. Officer & Director (Age 52, Pay $29.75k)Mr. Sunil Sawhney, Head of Clinical StudiesDr. Richard H. Tullis Ph.D., Consultant (Age 77) Who are some of Aethlon Medical's key competitors? Some companies that are related to Aethlon Medical include TransEnterix (TRXC), Titan Medical (TMDI), Pro-Dex (PDEX), Daxor (DXR), Modular Medical (MODD), Nemaura Medical (NMRD), Pulse Biosciences (PLSE), Isoray (ISR), Isoray (ISR), enVVeno Medical (NVNO), SANUWAVE Health (SNWV), GlucoTrack (GCTK), Integrity Applications (IGAP), STRATA Skin Sciences (SSKN) and Venus Concept (VERO). View all of AEMD's competitors. What other stocks do shareholders of Aethlon Medical own? Based on aggregate information from My MarketBeat watchlists, some companies that other Aethlon Medical investors own include Amarin (AMRN), Nokia Oyj (NOK), Vaxart (VXRT), VBI Vaccines (VBIV), Nabriva Therapeutics (NBRV), CRISPR Therapeutics (CRSP), Novavax (NVAX), OrganiGram (OGI), AT&T (T) and Aurora Cannabis (ACB). What is Aethlon Medical's stock symbol? Aethlon Medical trades on the NASDAQ under the ticker symbol "AEMD." How do I buy shares of Aethlon Medical? Shares of AEMD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Aethlon Medical's stock price today? One share of AEMD stock can currently be purchased for approximately $0.99. How much money does Aethlon Medical make? Aethlon Medical (NASDAQ:AEMD) has a market capitalization of $15.67 million and generates $290,000.00 in revenue each year. The medical equipment provider earns $-10,420,000.00 in net income (profit) each year or ($0.70) on an earnings per share basis. How many employees does Aethlon Medical have? Aethlon Medical employs 10 workers across the globe. How can I contact Aethlon Medical? Aethlon Medical's mailing address is 9635 GRANITE RIDGE DRIVE SUITE 100, SAN DIEGO CA, 92123. The official website for Aethlon Medical is www.aethlonmedical.com. The medical equipment provider can be reached via phone at (858) 459-7800 or via email at susan@sanoonan.com. This page (NASDAQ:AEMD) was last updated on 7/6/2022 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply. MarketBeat Resources Premium Research Tools MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools. Discover All Access Market Data and Calendars Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free. View Market Data Investing Education and Resources Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more. Financial Terms Details Here
